Related Experiment Video

Updated: Jun 24, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

How much does hypertension affect cognition?: explained variance in cross-sectional analysis of non-demented

Stefan Knecht1, Heike Wersching, Hubertus Lohmann

  • 1Department of Neurology, University of Muenster, Albert-Schweitzer-Strasse 33, 48149 Muenster, Germany. knecht@uni-muenster.de

Journal of the Neurological Sciences
|March 24, 2009
PubMed

Insights

High blood pressure (hypertension) significantly impacts cognitive function, explaining up to 11% of cognitive variance in midlife adults. Managing hypertension is crucial for preventing cognitive decline and dementia risk.

Area of Science:

  • Neurology
  • Cardiology
  • Public Health

Background:

  • Vascular pathology is a known contributor to cognitive impairment and dementia risk.
  • Hypertension is a prevalent and modifiable vascular risk factor.

Purpose of the Study:

  • To quantify the impact of systolic blood pressure (sBP) on cognitive performance variance in non-demented adults.
  • To estimate the contribution of hypertension to cognitive impairment and subsequent dementia risk.

Main Methods:

  • Recruitment of 525 community-dwelling individuals (aged 40-85) from Muenster, Germany.
  • Comprehensive cognitive testing battery and assessment of vascular risk factors (e.g., sBP, HbA1c, cholesterol, BMI, smoking).
  • Multiple linear regression analysis stratified by age group to determine variance explained by sBP.

Main Results:

  • Systolic blood pressure explained up to 11% of the variance in cognitive performance in midlife age groups.
  • Vascular risk factors, including sBP, were assessed in relation to cognitive function.
  • The study focused on non-demented, community-dwelling individuals.

Conclusions:

  • Hypertension may account for a significant portion (up to 10%) of cognitive impairment in non-demented individuals.
  • Controlling hypertension is a key strategy for mitigating cognitive decline and reducing dementia risk.
  • These findings highlight the importance of vascular health for maintaining cognitive function throughout life.

More Related Videos

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...